deepGeneAI-001

N/A

Report date: 2026/05/12 09:17:17

Base Information

Drug NamedeepGeneAI-001
Drug Alias NameNeoantigen Tumor Vaccine Therapy (deepGeneAI)Personalized mRNA Cancer Vaccine (deepGeneAI)deepGeneAI-001
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccinesVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Rui Jin Hospital
China Registration ClassN/A

Develop Information

Active CompaniesBio-X Institutes of Shanghai Jiao Tong UniversitydeepGeneAIShanghai Rui Jin Hospital
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A